Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
For the Indian Bariatric Surgery Outcome Reporting (IBSOR) Group, Baig SJ, Priya P, Mahawar KK, Shah S
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
It has gained attention for its remarkable healing properties, particularly in repairing tendons, ligaments, muscles and the gut lining
Both readings are single-lot documentation, not a trial specification
This is a reminder that, as part of our ongoing efforts to meet federal and state regulatory requirements, all participating providers are required to complete the Americans with Disabilities Act (ADA) Compliance Attestation
US$ 25.88
US$ 25.17
US$ 23.18
US$ 20.44
US$ 27.17
